Ifosfamide/liposomal daunorubicin is a well tolerated and active first-line chemotherapy regimen in advanced soft tissue sarcoma: results of a phase II study (Q46558402)
Jump to navigation
Jump to search
scientific article published in August 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Ifosfamide/liposomal daunorubicin is a well tolerated and active first-line chemotherapy regimen in advanced soft tissue sarcoma: results of a phase II study |
scientific article published in August 2005 |
Statements
1 reference
Ifosfamide/liposomal daunorubicin is a well tolerated and active first-line chemotherapy regimen in advanced soft tissue sarcoma: results of a phase II study (English)
1 reference
Ulrich Keilholz
1 reference
Gero Hütter
1 reference
Eckhard Thiel
1 reference
Jan M Siehl
1 reference
Alexander Schmittel
1 reference
Peter M Deckert
1 reference
Hubert Szelényi
1 reference
1 August 2005
1 reference
1 reference
104
1 reference
3
1 reference
611-617
1 reference
Identifiers
1 reference
1 reference